0000899243-22-034751.txt : 20221102 0000899243-22-034751.hdr.sgml : 20221102 20221102151038 ACCESSION NUMBER: 0000899243-22-034751 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221031 FILED AS OF DATE: 20221102 DATE AS OF CHANGE: 20221102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BB BIOTECH AG CENTRAL INDEX KEY: 0000924223 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39200 FILM NUMBER: 221353659 BUSINESS ADDRESS: STREET 1: SCHWERTSTRASSE 6 CITY: SCHAFFHAUSEN STATE: V8 ZIP: 8200 BUSINESS PHONE: 411724 59 59 MAIL ADDRESS: STREET 1: SCHWERTSTRASSE 6 CITY: SCHAFFHAUSEN STATE: V8 ZIP: 8200 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIOTECH GROWTH N V CENTRAL INDEX KEY: 0001259869 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39200 FILM NUMBER: 221353660 MAIL ADDRESS: STREET 1: ARA HILL TOP BUILDING, UNIT A-5 STREET 2: PLETTERIJWEG OOST 1, CURACAO CITY: WILLEMSTAD STATE: P8 ZIP: 000000 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Black Diamond Therapeutics, Inc. CENTRAL INDEX KEY: 0001701541 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MAIN STREET, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-417-5868 MAIL ADDRESS: STREET 1: ONE MAIN STREET, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Aset Therapeutics, Inc. DATE OF NAME CHANGE: 20170321 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-10-31 0 0001701541 Black Diamond Therapeutics, Inc. BDTX 0001259869 BIOTECH GROWTH N V ARA HILL TOP BUILDING, UNIT A-5, PLETTERIJWEG OOST 1 CURACAO P8 00000 NETHERLANDS ANTILLES 0 0 1 0 0000924223 BB BIOTECH AG SCHWERTSTRASSE 6 SCHAFFHAUSEN V8 CH-8200 SWITZERLAND 0 0 1 0 Common Stock 2022-10-31 4 P 0 99801 2.2536 A 5377839 D Biotech Growth N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Black Diamond Therapeutics, Inc. held directly or indirectly by Biotech Growth N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Growth N.V. By: /s/Ivo Betschart 2022-11-02 By: /s/Martin Gubler 2022-11-02